S. Ismail et al., PARACETAMOL DISPOSITION IN THAI PATIENTS DURING AND AFTER TREATMENT OF FALCIPARUM-MALARIA, European Journal of Clinical Pharmacology, 48(1), 1995, pp. 65-69
Investigations in animals have suggested that conjugation of paracetam
ol may be reduced in malaria, We have measured plasma concentrations a
nd the urinary excretion of paracetamol and its phase II metabolites i
n eight Thai patients during uncomplicated falciparum malaria and in c
onvalescence, following a 1000 mg single oral dose. The apparent oral
clearance (Malaria, 3.6; Convalescence, 3.9; ml . min(-1) . kg(-1)), t
he elimination half-life (Malaria, 3.8; Convalescence, 3.7 h) and appa
rent volume of distribution (Malaria, 1.2; Convalescence, 1.2; 1 kg(-1
)) of paracetamol were similar during malaria and convalescence. In ad
dition, the urinary excretion of paracetamol and its major phase II me
tabolites and their formation clearances from paracetamol were not sig
nificantly different between the two study phases. These data show tha
t clinical malaria infection has no effect on the conjugation of parac
etamol in man.